As close to the business
as the decision needs.

Working with you to find the next business move, challenge it and make it happen.

Who it’s for

Microbiome companies ready to grow: founders, leadership and boards.

Innovation teams entering the field.

Investors and programmes backing microbiome companies.

A steel arch bridge over a frozen river, its far end disappearing into fog

What you are deciding.

  • Adoption & Commercialisation

    “Our product works. The market isn’t using it yet.”

    Evidence of what buyers will commit to, and where to invest next.

  • Strategic Partnerships & Business Development

    “Our next move depends on other organisations.”

    The right partners, their interest tested, and a route to agreement.

  • Adaptation & Reinvention

    “Our market is changing. We have to decide what the business becomes.”

    A direction the team owns, the first moves to make, and a story investors can back.

What changed.

More than ten microbiome mandates across diagnostics, therapeutics, CROs, platforms, medical devices, sampling, AI and multi-omics.

Selected outcomes reflecting client context and Bridgyz contribution. Client names withheld for confidentiality.

Microbiome testing · EU

€500k+ contracted revenue.

The case
The problem
No commercial activity and no pipeline. The offer was built for consumers.
What I did
Seven months as embedded CBO. Repositioned the offer from consumers to institutional buyers and built three new offer tracks.
Inside the business →
Agri-food research · Asia Pacific

6 weeks to a five-year microbiome roadmap, now in action.

The case
The problem
World-class science and no microbiome strategy. No line of sight from research to impact.
What I did
One week on site and five weeks on the report. Site visits across Asia and interviews. Mapped how the soil microbiome links to gut health outcomes.
What happened next
Grants, keynotes and new microbiome activities.
Inside the business →
Microbiome CRO · EU

Approved by the board: the company’s new strategy.

The case
The problem
The company was setting its strategy for the next stage.
What I did
Worked with the CEO and senior leadership team. Input on adoption in one market and a new adjacent market identified. Took part in two workshops with the team.
Inside the business →
Pharmacomicrobiomics · USA

$1M+ funding subsequently secured.

The case
The problem
A weak investor story and an unfocused pitch.
What I did
Rebuilt the offer and the investor story.
Regular conversations →

Start where the commitment feels right.

Focused advisory

01

One question

Your plan, tested against how buyers, partners and investors behave. Go, change or stop.

Duration Up to a day.

02

One room

A prepared session for the team to make its choices. I speak to two or three of you beforehand.

Duration Half a day or a full day.

03

Regular conversations

Before the moments that count: a board meeting, a negotiation, a raise.

Duration An agreed rhythm.

Hands-on involvement

04

Inside the businessFractional CBO

CBO-level business development, before you hire for it. We agree at the start what I take responsibility for. The decisions stay with you.

Duration Six weeks to twenty months, one to three days a week.

What you get

I combine analysis with direct conversations: your team, customers, partners and the other people who will decide what happens next.

One adviser, start to finish.

A straight answer, including when to stop.

Execution alongside your team.

Confidential. Potential conflicts are flagged early. Client information is not shared.

You don’t need a finished brief.
Start with what is unclear.

The first conversation is free and under an hour.